Response to Letter Regarding Article, “Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Stroke Is Better Than Low Doses”
Stroke - United States
doi 10.1161/strokeaha.114.007363
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2014
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)